Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 247-988-1 | CAS number: 26762-93-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 04 June 2012 - 02 October 2012
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Compliant to GLP and testing guidelines; adequate consistence between data, comments and conclusions.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 012
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.17 (Mutagenicity - In Vitro Mammalian Cell Gene Mutation Test)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- mammalian cell gene mutation assay
Test material
- Reference substance name:
- Diisopropylbenzene hydroperoxide
- EC Number:
- 247-988-1
- EC Name:
- Diisopropylbenzene hydroperoxide
- Cas Number:
- 26762-93-6
- Molecular formula:
- C12H18O2
- IUPAC Name:
- reaction mass of 1-(3-isopropylphenyl)-1-methylethyl hydroperoxide and 1-(4-isopropylphenyl)-1-methylethyl hydroperoxide
- Test material form:
- other: colorless to yellowish liquid
Constituent 1
Method
- Target gene:
- Thymidine Kinase
Species / strain
- Species / strain / cell type:
- mouse lymphoma L5178Y cells
- Details on mammalian cell type (if applicable):
- - Type and identity of media: RPMI 1640 medium containing L-Glutamine (2 mM), penicillin (100 U/mL), streptomycin (100 µg/mL) and sodium
pyruvate (200 µg/mL)
- Properly maintained: yes
- Periodically checked for Mycoplasma contamination: yes
- Periodically "cleansed" against high spontaneous background: yes
- Metabolic activation:
- with and without
- Metabolic activation system:
- rat liver S9 mix
- Test concentrations with justification for top dose:
- Experiments without S9 mix
Using a treatment volume of 1% in culture medium, the selected dose-levels were:
- 1.6, 3.1, 6.3, 12.5, 25 and 50 µg/mL for the first experiment (3-hour treatment),
- 0.6, 1.3, 2.5, 5, 10, 15 and 20 µg/mL for the second experiment (24-hour treatment).
Experiments without S9 mix
Using a treatment volume of 1% in culture medium, the selected dose-levels were:
- 1.6, 3.1, 6.3, 12.5, 25 and 50 µg/mL for the first experiment (3-hour treatment),
- 0.6, 1.3, 2.5, 5, 10, 15 and 20 µg/mL for the second experiment (24-hour treatment). - Vehicle / solvent:
- Vehicle used: dimethylsulfoxide
Justification for choice: test item was soluble in the vehicle at:
- 860 mg/mL for the preliminary toxicity test,
- 20 mg/mL for the first experiment and for the second experiment with S9 mix,
- 15 mg/mL for the second experiment without S9 mix and the third experiment.
Controls
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: methylmethanesulfonate (-S9 mix); cyclophosphamide (+S9 mix)
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium
DURATION
- Exposure duration: 3 and 24 hours
- Expression time (cells in growth medium): 48 hours
- Selection time (if incubation with a selection agent): 11-12 days
SELECTION AGENT (mutation assays): trifluorothymidine
DETERMINATION OF CYTOTOXICITY
- Method: cloning efficiency; relative total growth. - Evaluation criteria:
- IWGT recommendations were followed for the determination of a positive result, which should fulfill the following criteria:
- at least at one dose-level the mutation frequency minus the mutation frequency of the vehicle control (IMF) equals or exceeds the Global Evaluation Factor (GEF) of 126 x 10-6,
- a dose-related trend is demonstrated by a statistically significant trend test.
Unless an effect is considered as clearly positive, the reproducibility of a positive effect should be confirmed.
Noteworthy increases in the mutation frequency observed only at high levels of cytotoxicity (Adj. RTG lower than 10%), but with no evidence of mutagenicity at dose-levels with Adj. RTG between 10 and 20%, are not considered as positive results.
A test item may be considered as non-mutagenic when there is no culture showing an Adj. RTG value between 10 and 20% if (Moore et al., 2002):
- there is at least one negative data point between 20 and 25% Adj. RTG and no evidence of mutagenicity in a series of data points between 100 and 20% Adj. RTG,
- there is no evidence of mutagenicity in a series of data points between 100 and 25% and there is also a negative data point between 10 and 1% Adj. RTG.
Results and discussion
Test results
- Species / strain:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Remarks on result:
- other: strain/cell type: mouse lymphoma L5178Y cells
- Remarks:
- Migrated from field 'Test system'.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
negative
The test item was not mutagenic to mammalian cells in the presence or absence of metabolic activation. - Executive summary:
The potential of the test item (diisopropylbenzene monohydroperoxide in diisopropylbenzen) was evaluated in a Mouse Lymphoma Assay. The study was performed according to international guidelines (OECD guideline No. 476 and Council Regulation (EC) No. 440/2008 of 30 May 2008, Annex, Part B.17) and in compliance with the principles of Good Laboratory Practice.
Methods
After a preliminary toxicity test, Diisopropylbenzene monohydroperoxide, was tested in three independent experiments, with and/or without a metabolic activation system (S9 mix) prepared from a liver microsomal fraction (S9 fraction) of rats induced with Aroclor 1254.
Cultures of 20 mL at 5 x 105cells/mL (3-hour treatment) or cultures of 50 mL at 2 x 105cells/mL (24-hour treatment) were exposed to the test or control items, in the presence or absence of S9 mix (final concentration of S9 fraction 2%). During the treatment period, the cells were maintained as suspension culture in RPMI 1640 culture medium supplemented by heat inactivated horse serum at 5% (3-hour treatment) or 10% (24-hour treatment) in a 37°C, 5% CO2humidified incubator. For the 24-hour treatment, flasks were gently shaken at least once.
Cytotoxicity was measured by assessment of Adjusted Relative Total Growth (Adj. RTG), Adjusted Relative Suspension Growth (Adj. RSG) and Cloning Efficiency following the expression time (CE2).
The number of mutant clones (differentiating small and large colonies) was evaluated after expression of the mutant phenotype.
The test item was dissolved in dimethylsulfoxide (DMSO).
Results
With one exception which is not considered to have a biological impact on the validity of the study, the Cloning Efficiencies (CE2), the Suspension Growths (SG) and the mutation frequencies of the vehicle controls were as specified in the acceptance criteria. Moreover, the induced mutation frequencies obtained for the positive controls met the acceptance criteria specified in the study plan. The study was therefore considered as valid.
Since the test item was found severely cytotoxic in the preliminary test, the choice of the highest dose-level for the main test was based on the level of toxicity, according to the criteria specified in the international guidelines (decrease in Adj. RTG).
Experiments without S9 mix
Using a treatment volume of 1% in culture medium, the selected dose-levels were:
- 1.6, 3.1, 6.3, 12.5, 25 and 50 µg/mL for the first experiment (3-hour treatment),
- 0.6, 1.3, 2.5, 5, 10, 15 and 20 µg/mL for the second experiment (24-hour treatment).
Cytotoxicity
Following the 3-hour treatment, a marked toxicity was induced at 50 µg/mL, as shown by a 66% decrease in Adj. RTG.
Following the 24-hour treatment, a moderate to severe toxicity was induced at dose-levels = 10 µg/mL, as shown by a 43 to 97% decrease in Adj. RTG.
Mutagenicity
Following the 3- or 24-hour treatments, no relevant or dose-related increases in the mutation frequency were noted in comparison to the vehicle control. The results did not meet the criteria for a positive response.
Experiments with S9 mix
Using a treatment volume of 1% in culture medium, the selected dose-levels were as follows:
- 6.3, 12.5, 25, 50, 100 and 200 µg/mL for the first experiment,
- 12.5, 25, 50, 100, 150 and 200 µg/mL for the second experiment,
- 25, 50, 75, 100, 116.7, 133.3 and 150 µg/mL for the third experiment.
Cytotoxicity
Following the first experiment, a slight to severe toxicity was induced at dose-levels = 50 µg/mL, as shown by a 31 to 100% decrease in Adj. RTG.
Following the second experiment, a marked to severe toxicity was induced at dose-levels = 100 µg/mL, as shown by a 66 to 97% decrease in Adj. RTG. Following the third experiment, a moderate to severe toxicity was induced at dose-levels = 75 µg/mL, as shown by a 48 to 98% decrease in Adj. RTG.
Mutagenicity
No noteworthy increases in the mutation frequency, which could be considered as biologically relevant, were induced in any of the experiments.
Conclusion
The test item did not show any mutagenic activity in the mouse lymphoma assay, in the presence or in the absence of a rat metabolizing system.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.